-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-07-04
FSROF:OTC-FSROF (USD)
COMMON STOCK | Others |
Last Closing
USD 2Change
0.00 (0.00)%Market Cap
N/AVolume
N/AAnalyst Target
N/A![](https://ducovest.com/tools/assets/assets/images/analyst-meter.png)
N/A
Verdict
Values as of: 2024-07-04
COMMON STOCK | Others |
Last Closing
USD 2Change
0.00 (0.00)%Market Cap
N/AVolume
N/AAnalyst Target
N/AN/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
CSTNL | iShares VII Public Limited Com.. |
N/A |
USD 32.85B |
JDEPY | JDEPY |
N/A |
USD 9.92B |
IISHF | iShares III Public Limited Com.. |
N/A |
USD 9.10B |
ZKBGF | ZKB Gold ETF |
N/A |
USD 8.96B |
IHPCF | iShares Public Limited Company.. |
N/A |
USD 8.93B |
TOETF | Tosei Corporation |
N/A |
USD 7.70B |
CUYTY | Etablissementen Franz Colruyt .. |
N/A |
USD 7.56B |
EFMSF | ETFS Metal Securities Limited .. |
N/A |
USD 7.39B |
BCYIF | iShares Public Limited Company.. |
N/A |
USD 5.80B |
IIREF | iShares Public Limited Company.. |
N/A |
USD 5.32B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
EZA | iShares MSCI South Africa.. | 9.53 % | 0.59 % |
N/A |
USD 0.27B |
IRSA:LSE | iShares MSCI South Africa.. | 9.43 % | 0.00 % |
N/A |
USD 0.06B |
SRSA:LSE | iShares MSCI South Africa.. | 9.43 % | 0.00 % |
N/A |
USD 0.06B |
IBC4:XETRA | iShares MSCI South Africa.. | 8.53 % | 0.00 % |
N/A |
USD 0.06B |
SRSA:SW | iShares MSCI South Africa.. | 8.53 % | 0.00 % |
N/A |
USD 0.06B |
AFK | VanEck Africa Index ETF | 3.98 % | 0.78 % |
N/A |
USD 0.05B |
IBC4:F | iShares III Public Limite.. | 0.00 % | 0.00 % |
N/A |
USD 0.06B |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 10.50% | 71% | C- | 68% | D+ | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 10.50% | 71% | C- | 66% | D+ | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
There is nothing we particularly dislike